CGTX: FDA Agrees On Outcome
Cognition Therapeutics reaches alignment with FDA on vital aspects to support its new drug application for psychosis associated with dementia with Lewy bodies
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.